The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 1-13D Transplant Outcomes (2)

Fri. Oct 11, 2019 4:30 PM - 5:30 PM No.13 (Tokyo International Forum, 6F G602)

Chair: Kazuteru Ohashi (Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital)

Shohei Mizuno1, Masamitsu Yanada2, Koji Kawamura3, Motonori Mizutani1, Masayoshi Masuko4, Naoyuki Uchida5, Yukiyasu Ozawa6, Koji Iwato7, Kazuteru Ohashi8, Kazuhiro Ikegame9, Sung-Won Kim10, Heiwa Kanamori11, Tetsuya Eto12, Yoshinobu Kanda3, Takahiro Fukuda10, Yoshiko Atsuta13,14, Shingo Yano15, Akiyoshi Takami1 (1.Division of Hematology, Department of Internal Medicine, Aichi Medical University, 2.Department of Hematology and Cell Therapy, Aichi Cancer Center, 3.Division of Hematology, Saitama Medical Center, Jichi Medical University, 4.Division of Stem Cell Transplantation, Niigata University Hospital, 5.Department of Hematology, Toranomon Hospital, 6.Department of Hematology, Japanese Red Cross Nagoya First Hospital, 7.Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 8.Hematology Division, Komagome Hospital, 9.Division of Hematology, Hyogo College of Medicine, 10.Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 11.Department of Hematology, Kanagawa Cancer Center, 12.Department of Hematology, Hamanomachi Hospital, 13.Japanese Data Center for Hematopoietic Cell Transplantation, 14.Department of Healthcare Administration, Nagoya University Graduate School of Medicine, 15.Department of Oncology and Hematology, Jikei University School of Medicine)

Shinichi Fuchida1, Koji Kawamura2, Nobuhiro Tsukada3, Kumiko Kagawa4, Takahiro Karasuno5, Hiroshi Ohkawara6, Kensuke Usuki7, Atsushi Wake8, Yukinori Nakamura9, Yoshitaka Inoue10, Takahiro Fukuda11, Tatsuo Ichinohe12, Yoshiko Atsuta13, Kazutaka Sunami14, Hiroyuki Takamatsu15 (1.JCHO Kyoto Kuramaguchi Medical Center, Department of Hematology, 2.Jichi Medical University, Saitama Medical Center, Division of Hematology, 3.Japanese Red Cross Medical Center, Department of Hematology, 4.Tokushima University Hospital, Cell Therapy Center, 5.Rinku General Medical Center, Division of Hematology, 6.Fukushima Medical University Hospital, Department of Hematology, 7.NTT Medical Center Tokyo, Department of Hematology, 8.Toranomon Hospital, Kajigaya, Department of Hematology, 9.Yamaguchi University Hospital, Third Department of Internal Medicine, 10.Kumamoto University Hospital, Department of Hematology, 11.National Cancer Center Hospital, Hematopoietic Stem Cell Transplantation Division, 12.Hiroshima University, Department of Hematology and Oncology, 13.Japanese Data Center for Hematopoietic Cell Transplantation, 14.NHO Okayama Medical Center, Department of Hematology, 15.Kanazawa University Graduate School of Medical Science, Department of Hematology)

Satoshi Yamasaki1, Dai Chihara2, Isao Yoshida3, Kyuhei Kohda4, Masashi Sawa5, Hiroatsu Ago6, Kazuto Togitani7, Yuju Ohno8, Junji Tanaka9, Takahiro Fukuda10, Yoshiko Atsuta11, Junji Suzumiya12, Ritsuro Suzuki12 (1.Dept. Hematol, Kyushu Medical Center, Fukuoka, Japan, 2.Center for Cancer Research, NCI, NIH, Bethesda, MD, USA, 3.Dept. Hematol Oncol, Shikoku Cancer Center, Matsuyama, Japan, 4.Dept. Hematol Oncol, Asahikawa Red Cross Hospital, Asashikawa, Japan, 5.Dept. Hematol Oncol, Anjo Kosei Hospital, Anjo, Japan, 6.Dept. Hematol Oncol, Shimane Prefectural Central Hospital, Izumo, Japan, 7.Dept. Hematol and Resp Med, Kochi Medical School, Kochi, Japan, 8.Dept. Internal Med, Kitakyushu Municipal Medical Center, Kitakyushu, Japan, 9.Dept. Hematol, Tokyo Womens Medical University, Tokyo, Japan, 10.HSCT Div, National Cancer Center Hospital, Tokyo, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 12.Dept Oncol Hematol, Shimane University Hospital, Izumo, Japan)